Constitutive activation of Nrf2 by inactivating mutations in KEAP1 or activating mutations in Nrf2 interferes with the KEAP1-Nrf2 interaction, reprogramming glucose metabolism to support cell proliferation and contribute to cancer progression [11,12]. The gene discussed is KEAP1; the disease is cancer.